Lisa-Mari Mörk1, Bengt Isaksson2, Nicola Boran3, Bo-Göran Ericzon3, Stephen Strom4, Björn Fischler5, Ewa Ellis3. 1. Division of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 14186, Sweden ; Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 14186, Sweden ; Department of Laboratory Medicine, Karolinska Institutet, Stockholm 14186, Sweden. 2. Division of Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 14186, Sweden. 3. Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 14186, Sweden. 4. Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15213, USA. 5. Division of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 14186, Sweden.
Abstract
BACKGROUND: Primary human hepatocytes are a useful in vitro model system to examine hepatic biochemical pathways, liver disorders and/or pharmacotherapies. This system can also be used for transport studies to investigate uptake and excretion of bile acids. Proper modeling of hepatic function requires careful attention to media components, and culture substrates and conditions. OBJECTIVES: To examine the effects of different culture media and conditions on bile acid transport in cultured human hepatocytes. METHODS AND RESULTS: Hepatocytes cultured in Williams' medium E showed an increase in both uptake and excretion of taurocholate compared to cells cultured in Dulbecco's Modified Eagle Medium (DMEM). Supplementation of DMEM with glutathione or ascorbic acid did not compensate for the lower transport. The difference can be explained by lower mRNA expression of the transporter proteins sodium taurocholate cotransporting polypeptide (NTCP) and bile salt export pump (BSEP; ABCB11) when cultured in DMEM. Hepatocytes cultured in DMEM also display fewer and smaller bile canaliculi. Following extended time in culture supplementation of Williams' medium E with dexamethasone increased the expression of NTCP and BSEP. CONCLUSION: Williams' medium E is superior to DMEM for transport studies in primary human hepatocytes. Supplementation with dexamethasone increase mRNA levels of NTCP and BSEP.
BACKGROUND: Primary human hepatocytes are a useful in vitro model system to examine hepatic biochemical pathways, liver disorders and/or pharmacotherapies. This system can also be used for transport studies to investigate uptake and excretion of bile acids. Proper modeling of hepatic function requires careful attention to media components, and culture substrates and conditions. OBJECTIVES: To examine the effects of different culture media and conditions on bile acid transport in cultured human hepatocytes. METHODS AND RESULTS: Hepatocytes cultured in Williams' medium E showed an increase in both uptake and excretion of taurocholate compared to cells cultured in Dulbecco's Modified Eagle Medium (DMEM). Supplementation of DMEM with glutathione or ascorbic acid did not compensate for the lower transport. The difference can be explained by lower mRNA expression of the transporter proteins sodium taurocholate cotransporting polypeptide (NTCP) and bile salt export pump (BSEP; ABCB11) when cultured in DMEM. Hepatocytes cultured in DMEM also display fewer and smaller bile canaliculi. Following extended time in culture supplementation of Williams' medium E with dexamethasone increased the expression of NTCP and BSEP. CONCLUSION:Williams' medium E is superior to DMEM for transport studies in primary human hepatocytes. Supplementation with dexamethasone increase mRNA levels of NTCP and BSEP.
Entities:
Keywords:
AA, ascorbic acid; BSEP; BSEP, bile salt export pump; CgamF, cholylglycylamido-fluorescein; DMEM, Dulbecco's Modified Eagle Medium; GSH, glutathione; HBSS, Hank's Balanced Salt Solution; MRP2, multidrug resistance protein 2; NTCP; NTCP, sodium taurocholate cotransporting polypeptide; OATP, organic anion-transporting polypeptide; WE, Williams' medium E; bile acid transport; dexamethasone; primary human hepatocytes
Authors: E G Schuetz; D Li; C J Omiecinski; U Muller-Eberhard; H K Kleinman; B Elswick; P S Guzelian Journal: J Cell Physiol Date: 1988-03 Impact factor: 6.384
Authors: E Ellis; B Goodwin; A Abrahamsson; C Liddle; A Mode; M Rudling; I Bjorkhem; C Einarsson Journal: Hepatology Date: 1998-02 Impact factor: 17.425
Authors: S S Strautnieks; L N Bull; A S Knisely; S A Kocoshis; N Dahl; H Arnell; E Sokal; K Dahan; S Childs; V Ling; M S Tanner; A F Kagalwalla; A Németh; J Pawlowska; A Baker; G Mieli-Vergani; N B Freimer; R M Gardiner; R J Thompson Journal: Nat Genet Date: 1998-11 Impact factor: 38.330
Authors: Vsevolod E Kostrubsky; Stephen C Strom; Janean Hanson; Ellen Urda; Kelly Rose; James Burliegh; Philip Zocharski; Hongbo Cai; Jacqueline F Sinclair; Jasminder Sahi Journal: Toxicol Sci Date: 2003-08-27 Impact factor: 4.849
Authors: Hee Eun Kang; Melina M Malinen; Chitra Saran; Paavo Honkakoski; Kim L R Brouwer Journal: Drug Metab Dispos Date: 2019-08-01 Impact factor: 3.922
Authors: Melina M Malinen; Katsuaki Ito; Hee Eun Kang; Paavo Honkakoski; Kim L R Brouwer Journal: Eur J Pharm Sci Date: 2019-01-24 Impact factor: 4.384